SynthesisFrontiers in cardiovascular medicine2026
Prevalence and influencing factors of cognitive frailty in patients with chronic heart failure: a meta-analysis.
Synthesis in Frontiers in cardiovascular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objective: To systematically investigate the prevalence and influencing factors of cognitive frailty in patients with chronic heart failure, and to provide evidence-based support for subsequent clinical intervention development. Methods: We retrieved relevant studies focusing on the prevalence and influencing factors of cognitive frailty in patients with chronic heart failure from Embase, Cochrane Library, PubMed, Web of Science, CINAHL, SinoMed, CNKI, VIP, and Wanfang databases. The search period covered from the inception of each database to December 2025. Two researchers independently conducted study screening, data extraction, and methodological quality assessment. Meta-analysis was performed using Stata 15.0 software. Results: Fourteen studies involving 5,127 patients with chronic heart failure were included, among which 1,875 cases of cognitive frailty were reported, and 30 risk factors were identified. Meta-analysis showed that the pooled prevalence of cognitive impairment in patients with chronic heart failure was 39.3% (95% CI: 31.0%-47.7%). Further analysis identified age, age ≥ 80 years, New York Heart Association (NYHA) classification, comorbidity burden, polypharmacy, malnutrition, and depression as significant risk factors for cognitive impairment in this population. Higher educational attainment, engaging in physical exercise ≥ 3 times per week, and regular participation in intellectual activities were confirmed as protective factors against cognitive impairment in patients with chronic heart failure. Conclusion: Current evidence confirms that cognitive impairment is highly prevalent among patients with chronic heart failure, and its occurrence is influenced by multiple modifiable and non-modifiable risk factors. Therefore, clinical healthcare providers should strengthen routine cognitive function screening for this population, and implement targeted interventions based on the identified risk factors to delay the onset of cognitive impairment and improve overall patient prognosis. Systematic Review Registration: https://www.crd.york.ac.uk/PROSPERO/view/CRD420251247352, PROSPERO CRD420251247352.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.